OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1596
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1596
Showing 26-50 of 1596 citing articles:
Causes and consequences of clonal hematopoiesis
Lachelle D. Weeks, Benjamin L. Ebert
Blood (2023) Vol. 142, Iss. 26, pp. 2235-2246
Open Access | Times Cited: 40
Lachelle D. Weeks, Benjamin L. Ebert
Blood (2023) Vol. 142, Iss. 26, pp. 2235-2246
Open Access | Times Cited: 40
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 39
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 39
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 697-718
Open Access | Times Cited: 37
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 697-718
Open Access | Times Cited: 37
A new genomic framework to categorize pediatric acute myeloid leukemia
Masayuki Umeda, Jing Ma, Tamara Westover, et al.
Nature Genetics (2024) Vol. 56, Iss. 2, pp. 281-293
Open Access | Times Cited: 34
Masayuki Umeda, Jing Ma, Tamara Westover, et al.
Nature Genetics (2024) Vol. 56, Iss. 2, pp. 281-293
Open Access | Times Cited: 34
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1142-1165
Open Access | Times Cited: 23
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1142-1165
Open Access | Times Cited: 23
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood (2024) Vol. 143, Iss. 19, pp. 1891-1902
Open Access | Times Cited: 21
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood (2024) Vol. 143, Iss. 19, pp. 1891-1902
Open Access | Times Cited: 21
One thousand patients with essential thrombocythemia: the Mayo Clinic experience
Naseema Gangat, Omer Karrar, Aref Al‐Kali, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Naseema Gangat, Omer Karrar, Aref Al‐Kali, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review
Samuel Bogdan Todor, Cristian Ichim, Adrian Boicean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8407-8423
Open Access | Times Cited: 17
Samuel Bogdan Todor, Cristian Ichim, Adrian Boicean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8407-8423
Open Access | Times Cited: 17
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Talha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Talha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T. Gerds, Claire Harrison, Jean‐Jacques Kiladjian, et al.
Blood Advances (2024) Vol. 8, Iss. 17, pp. 4511-4522
Open Access | Times Cited: 15
Aaron T. Gerds, Claire Harrison, Jean‐Jacques Kiladjian, et al.
Blood Advances (2024) Vol. 8, Iss. 17, pp. 4511-4522
Open Access | Times Cited: 15
Ayalew Tefferi, Maymona Abdelmagid, Giuseppe Gaetano Loscocco, et al.
American Journal of Hematology (2025)
Open Access | Times Cited: 3
Genomic and Clinicopathological Characterization of CRLF2‐Rearranged Mixed Phenotype Acute Leukemia
Lina Han, Ruifang Zheng, Franklin Fuda, et al.
Pediatric Blood & Cancer (2025)
Closed Access | Times Cited: 2
Lina Han, Ruifang Zheng, Franklin Fuda, et al.
Pediatric Blood & Cancer (2025)
Closed Access | Times Cited: 2
Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Menglin Li, Yimeng Li, Qingyuan Qu, et al.
Cancer Letters (2025), pp. 217460-217460
Closed Access | Times Cited: 2
Menglin Li, Yimeng Li, Qingyuan Qu, et al.
Cancer Letters (2025), pp. 217460-217460
Closed Access | Times Cited: 2
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
Sibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Sibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
Shai Shimony, Maximilian Stahl, Richard M. Stone
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Shai Shimony, Maximilian Stahl, Richard M. Stone
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification
Jürgen Thiele, H. M. Kvasnicka, Umberto Gianelli, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Jürgen Thiele, H. M. Kvasnicka, Umberto Gianelli, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms
Jürgen Thiele, Hans Michael Kvasnicka, Attilio Orazi, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 166-179
Closed Access | Times Cited: 59
Jürgen Thiele, Hans Michael Kvasnicka, Attilio Orazi, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 166-179
Closed Access | Times Cited: 59
The International Consensus Classification of acute myeloid leukemia
Olga K. Weinberg, Anna Porwit, Attilio Orazi, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 27-37
Closed Access | Times Cited: 56
Olga K. Weinberg, Anna Porwit, Attilio Orazi, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 27-37
Closed Access | Times Cited: 56
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz, et al.
Blood Advances (2022) Vol. 7, Iss. 9, pp. 1899-1909
Open Access | Times Cited: 52
Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz, et al.
Blood Advances (2022) Vol. 7, Iss. 9, pp. 1899-1909
Open Access | Times Cited: 52
Myelodysplastic syndromes
Huan Li, Fang‐Wen Hu, Robert Peter Gale, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 45
Huan Li, Fang‐Wen Hu, Robert Peter Gale, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 45
The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia
Martina Rudelius, Olga K. Weinberg, Charlotte M. Niemeyer, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 113-130
Closed Access | Times Cited: 41
Martina Rudelius, Olga K. Weinberg, Charlotte M. Niemeyer, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 113-130
Closed Access | Times Cited: 41
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population
Isabelle A. van Zeventer, Aniek O. de Graaf, Jonas B. Salzbrunn, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1017-1031.e4
Open Access | Times Cited: 39
Isabelle A. van Zeventer, Aniek O. de Graaf, Jonas B. Salzbrunn, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1017-1031.e4
Open Access | Times Cited: 39
DDX41-associated susceptibility to myeloid neoplasms
Hideki Makishima, Teresa V. Bowman, Lucy A. Godley
Blood (2022) Vol. 141, Iss. 13, pp. 1544-1552
Open Access | Times Cited: 38
Hideki Makishima, Teresa V. Bowman, Lucy A. Godley
Blood (2022) Vol. 141, Iss. 13, pp. 1544-1552
Open Access | Times Cited: 38
Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis
Ayalew Tefferi, Animesh Pardanani, Naseema Gangat
Haematologica (2023) Vol. 108, Iss. 11, pp. 2919-2932
Open Access | Times Cited: 36
Ayalew Tefferi, Animesh Pardanani, Naseema Gangat
Haematologica (2023) Vol. 108, Iss. 11, pp. 2919-2932
Open Access | Times Cited: 36
